Urine and serum biomonitoring of exposure to environmental estrogens I: Bisphenol A in pregnant women

Food and Chemical Toxicology

Volumn 92, Issue , 2016, Pages 129-142

  Teeguarden, Justin G ^a,b   Twaddle, Nathan C ^c   Churchwell, Mona I ^c   Doerge, Daniel R ^c  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomonitoring; Bisphenol A; Endocrine disruptors; Exposure; Pharmacokinetics; Pregnancy

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ESTROGEN; PHENOL DERIVATIVE; POLLUTANT;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; METABOLITE; NORMAL HUMAN; PREGNANT WOMAN; URINALYSIS; URINE VOLUME; YOUNG ADULT; ADOLESCENT; ANALYSIS; BLOOD; FOOD CONTAMINATION; LIMIT OF DETECTION; PHARMACOKINETICS; POLLUTANT; PREGNANCY; TISSUE DISTRIBUTION; URINE;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGENS, NON-STEROIDAL; FEMALE; FOOD CONTAMINATION; HUMANS; LIMIT OF DETECTION; PHENOLS; PREGNANCY; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84963568244     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.03.023     Document Type: Article

References (124)

1. Ahmad Khanbeigi R., Kumar A., Sadouki F., Lorenz C., Forbes B., Dailey L.A., Collins H. The delivered dose: applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. J. Control Release 2012, 162:259-266.
2. Arbuckle T.E., Davis K., Marro L., Fisher M., Legrand M., LeBlanc A., Gaudreau E., Foster W.G., Choeurng V., Fraser W.D. Phthalate and bisphenol A exposure among pregnant women in Canada-results from the MIREC study. Environ. Int. 2014, 68:55-65.
3. Arbuckle T.E., Davis K., Marro L., Fisher M., Legrand M., LeBlanc A., Gaudreau E., Foster W.G., Choeurng V., Fraser W.D., Group M.S. Phthalate and bisphenol A exposure among pregnant women in Canada-results from the MIREC study. Environ. Int. 2014, 68:55-65.
4. Arbuckle T.E., Weiss L., Fisher M., Hauser R., Dumas P., Berube R., Neisa A., LeBlanc A., Lang C., Ayotte P., Walker M., Feeley M., Koniecki D., Tawagi G. Maternal and infant exposure to environmental phenols as measured in multiple biological matrices. Sci. Total Environ. 2015, 508:575-584.
5. Aris A. Estimation of bisphenol A (BPA) concentrations in pregnant women, fetuses and nonpregnant women in Eastern Townships of Canada. Reprod. Toxicol. 2014, 45:8-13.
6. Bendridi N., Mappus E., Grenot C., Lejeune H., Yves Cuilleron C., Pugeat M. Intravenous injection of human sex steroid hormone-binding globulin in mouse decreases blood clearance rate and testicular accumulation of orally administered [2-125I]iodobisphenol A. Steroids 2002, 67:637-645.
7. Braun J.M., Yolton K., Dietrich K.N., Hornung R., Ye X., Calafat A.M., Lanphear B.P. Prenatal bisphenol A exposure and early childhood behavior. Environ. Health Perspect. 2009, 117:1945-1952.
8. Burstyn I., Martin J.W., Beesoon S., Bamforth F., Li Q., Yasui Y., Cherry N.M. Maternal exposure to bisphenol-A and fetal growth restriction: a case-referent study. Int. J. Environ. Res. Public Health 2013, 10:7001-7014.
9. Calafat A.M., Koch H.M., Swan S.H., Hauser R., Goldman L.R., Lanphear B.P., Longnecker M.P., Rudel R.A., Teitelbaum S.L., Whyatt R.M., Wolff M.S. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res. BCR 2013, 15:403.
10. Calafat A.M., Longnecker M.P., Koch H.M., Swan S.H., Hauser R., Goldman L.R., Lanphear B.P., Rudel R.A., Engel S.M., Teitelbaum S.L., Whyatt R.M., Wolff M.S. Optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology. Environ. Health Perspect. 2015, 123:A166-168.
11. Casas L., Fernandez M.F., Llop S., Guxens M., Ballester F., Olea N., Irurzun M.B., Rodriguez L.S., Riano I., Tardon A., Vrijheid M., Calafat A.M., Sunyer J., Project I. Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Environ. Int. 2011, 37:858-866.
12. Casas M., Chevrier C., Hond E.D., Fernandez M.F., Pierik F., Philippat C., Slama R., Toft G., Vandentorren S., Wilhelm M., Vrijheid M. Exposure to brominated flame retardants, perfluorinated compounds, phthalates and phenols in European birth cohorts: ENRIECO evaluation, first human biomonitoring results, and recommendations. Int. J. Hyg. Environ. Health 2013, 216:230-242.
13. Casas M., Valvi D., Ballesteros-Gomez A., Gascon M., Fernandez M.F., Garcia-Esteban R., Iniguez C., Martinez D., Murcia M., Monfort N., Luque N., Rubio S., Ventura R., Sunyer J., Vrijheid M. Exposure to bisphenol A and phthalates during pregnancy and ultrasound measures of fetal growth in the INMA-Sabadell cohort. Environ. Health Perspect. 2015, 124:521-528.
14. Caserta D., Bordi G., Ciardo F., Marci R., La Rocca C., Tait S., Bergamasco B., Stecca L., Mantovani A., Guerranti C., Fanello E.L., Perra G., Borghini F., Focardi S.E., Moscarini M. The influence of endocrine disruptors in a selected population of infertile women. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 2013, 29:444-447.
15. Caserta D., Ciardo F., Bordi G., Guerranti C., Fanello E., Perra G., Borghini F., La Rocca C., Tait S., Bergamasco B., Stecca L., Marci R., Lo Monte G., Soave I., Focardi S., Mantovani A., Moscarini M. Correlation of endocrine disrupting chemicals serum levels and white blood cells gene expression of nuclear receptors in a population of infertile women. Int. J. Endocrinol. 2013, 2013:510703.
16. Chevalier N., Brucker-Davis F., Lahlou N., Coquillard P., Pugeat M., Pacini P., Panaia-Ferrari P., Wagner-Mahler K., Fenichel P. A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development. Hum. Reprod. 2015, 30:447-453.
17. Chevrier J., Gunier R.B., Bradman A., Holland N.T., Calafat A.M., Eskenazi B., Harley K.G. Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ. Health Perspect. 2013, 121:138-144.
18. Chou W.C., Chen J.L., Lin C.F., Chen Y.C., Shih F.C., Chuang C.Y. Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan. Environ. Health 2011, 10:94.
19. Churchwell M.I., Camacho L., Vanlandingham M.M., Twaddle N.C., Sepehr E., Delclos K.B., Fisher J.W., Doerge D.R. Comparison of life-stage-dependent internal dosimetry for bisphenol A, ethinyl estradiol, a reference estrogen, and endogenous estradiol to test an estrogenic mode of action in Sprague Dawley rats. Toxicol. Sci. 2014, 139:4-20.
20. Coecke S., Pelkonen O., Leite S.B., Bernauer U., Bessems J.G., Bois F.Y., Gundert-Remy U., Loizou G., Testai E., Zaldivar J.M. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. Toxicol. In Vitro 2013, 27:1570-1577.
21. Coughlin J.L., Thomas P.E., Buckley B. Inhibition of genistein glucuronidation by bisphenol A in human and rat liver microsomes. Drug Metab. Dispos. 2012, 40:481-485.
22. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol. 2008, 228:114-134.
23. Doerge D.R., Twaddle N.C., Vanlandingham M., Brown R.P., Fisher J.W. Distribution of bisphenol A into tissues of adult, neonatal, and fetal Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2011, 255:261-270.
24. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2010, 247:158-165.
25. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys. Toxicol. Lett. 2011, 207:298-305.
26. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice. Toxicol. Lett. 2012, 211:114-119.
27. Doerge D.R., Twaddle N.C., Woodling K.A., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol. Appl. Pharmacol. 2010, 248:1-11.
28. Doerge D.R., Vanlandingham M., Twaddle N.C., Delclos K.B. Lactational transfer of bisphenol a in Sprague-Dawley rats. Toxicol. Lett. 2010, 199:372-376.
29. Donohue K.M., Miller R.L., Perzanowski M.S., Just A.C., Hoepner L.A., Arunajadai S., Canfield S., Resnick D., Calafat A.M., Perera F.P., Whyatt R.M. Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children. J. Allergy Clin. Immunol. 2013, 131:736-742.
30. Draganov D.I., Markham D.A., Beyer D., Waechter J.M., Dimond S.S., Budinsky R.A., Shiotsuka R.N., Snyder S.A., Ehman K.D., Hentges S.G. Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration. Toxicol. 2015, 333:168-178.
31. European Food Safety Authority Opinion of the scientific panel on food additives, flavourings,processing aids and materials in contact with food on a request from the commission related to 2,2-bis(4-hydroxyphenyl)propane (Bisphenol A). EFSA J. 2007, 428:1-75.
32. Fenichel P., Dechaux H., Harthe C., Gal J., Ferrari P., Pacini P., Wagner-Mahler K., Pugeat M., Brucker-Davis F. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum. Reprod. 2012, 27:983-990.
33. Fisher J.W., Twaddle N.C., Vanlandingham M., Doerge D.R. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol. Appl. Pharmacol. 2011, 257:122-136.
34. Food and Drug Administration Exposure to Bisphenol A (BPA) for infants, toblers and adults from the consumption of infant formula, toddler food and adult (canned) food. Division of Biotechnology and GRAS Notice Reivew, C.T 2009, Food and Drug Administration, Wahington D.C.
35. Gayrard V., Lacroix M.Z., Collet S.H., Viguie C., Bousquet-Melou A., Toutain P.L., Picard-Hagen N. High bioavailability of Bisphenol A from sublingual exposure. Environ. Health Perspect. 2013, 121:951-956.
36. Geens T., Apelbaum T.Z., Goeyens L., Neels H., Covaci A. Intake of bisphenol A from canned beverages and foods on the Belgian market. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2010, 27:1627-1637.
37. Gerona R.R., Woodruff T.J., Dickenson C.A., Pan J., Schwartz J.M., Sen S., Friesen M.W., Fujimoto V.Y., Hunt P.A. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ. Sci. Technol. 2013, 47:12477-12485.
38. Guida M., Troisi J., Ciccone C., Granozio G., Cosimato C., Di Spiezio Sardo A., Ferrara C., Guida M., Nappi C., Zullo F., Di Carlo C. Bisphenol A and congenital developmental defects in humans. Mutat. Res. 2015, 774:33-39.
39. Hormann A.M., Vom Saal F.S., Nagal S.C., Stalhut R.W., Moyer C.L., Ellersieck M.R., Welshons W.V., Toutain P.L., Taylor J.A. Holding thermal paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of Bisphenol A(BPA). PLoS One 2014, 9:1-12.
40. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
41. Judson R., Houck K., Martin M., Knudsen T., Thomas R.S., Sipes N., Shah I., Wambaugh J., Crofton K. In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme. Basic Clin. Pharmacol. Toxicol. 2014, 115:69-76.
42. Jung H., Hong Y., Lee D., Pang K., Kim Y. The association between some endocrine disruptors in human plasma and the occurrence of congenital hypothyroidism. Environ. Toxicol. Pharmacol. 2013, 35:278-283.
43. Kishi R., Kobayashi S., Ikeno T., Araki A., Miyashita C., Itoh S., Sasaki S., Okada E., Kobayashi S., Kashino I., Itoh K., Nakajima S. Ten years of progress in the Hokkaido birth cohort study on environment and children's health: cohort profile-updated 2013. Environ. Health Prev. Med. 2013, 18:429-450.
44. Klein S., Maggioni S., Bucher J., Mueller D., Niklas J., Shevchenko V., Mauch K., Heinzle E., Noor F. In silico modeling for the prediction of dose and pathway-related adverse effects in humans from in vitro repeated-dose studies. Toxicol. Sci. 2016, 149:55-66.
45. Kosarac I., Kubwabo C., Lalonde K., Foster W. A novel method for the quantitative determination of free and conjugated bisphenol A in human maternal and umbilical cord blood serum using a two-step solid phase extraction and gas chromatography/tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 898:90-94.
46. Kurebayashi H., Okudaira K., Ohno Y. Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans. Toxicol. Lett. 2010, 198:210-215.
47. Kuroda N., Kinoshita Y., Sun Y., Wada M., Kishikawa N., Nakashima K., Makino T., Nakazawa H. Measurement of bisphenol A levels in human blood serum and ascitic fluid by HPLC using a fluorescent labeling reagent. J. Pharm. Biomed. Anal. 2003, 30:1743-1749.
48. LaKind J.S., Naiman D.Q. Temporal trends in bisphenol A exposure in the United States from 2003-2012 and factors associated with BPA exposure: spot samples and urine dilution complicate data interpretation. Environ. Res. 2015, 142:84-95.
49. Lathi R.B., Liebert C.A., Brookfield K.F., Taylor J.A., vom Saal F.S., Fujimoto V.Y., Baker V.L. Conjugated bisphenol A in maternal serum in relation to miscarriage risk. Fertil. Steril. 2014, 102:123-128.
50. Lee Y.J., Ryu H.Y., Kim H.K., Min C.S., Lee J.H., Kim E., Nam B.H., Park J.H., Jung J.Y., Jang D.D., Park E.Y., Lee K.H., Ma J.Y., Won H.S., Im M.W., Leem J.H., Hong Y.C., Yoon H.S. Maternal and fetal exposure to bisphenol A in Korea. Reprod. Toxicol. 2008, 25:413-419.
51. Liao C., Kannan K. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ. Sci. Technol. 2012, 46:5003-5009.
52. Loganathan S.N., Kannan K. Occurrence of bisphenol A in indoor dust from two locations in the eastern United States and implications for human exposures. Arch. Environ. Contam. Toxicol. 2011, 61:68-73.
53. Martina C.A., Weiss B., Swan S.H. Lifestyle behaviors associated with exposures to endocrine disruptors. NeuroToxicol. 2012, 33:1427-1433.
54. Mazur C.S., Marchitti S.A., Dimova M., Kenneke J.F., Lumen A., Fisher J. Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment. Toxicol. Sci. 2012, 128:317-325.
55. Meeker J.D., Cantonwine D.E., Rivera-Gonzalez L.O., Ferguson K.K., Mukherjee B., Calafat A.M., Ye X., Anzalota Del Toro L.V., Crespo-Hernandez N., Jimenez-Velez B., Alshawabkeh A.N., Cordero J.F. Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ. Sci. Technol. 2013, 47:3439-3447.
56. Moors S., Diel P., Degen G.H. Toxicokinetics of bisphenol A in pregnant DA/Han rats after single i.v. application. Arch. Toxicol. 2006, 80:647-655.
57. Morgan M.K., Jones P.A., Calafat A.M., Ye X., Croghan C.W., Chuang J.C., Wilson N.K., Clifton M.S., Figueroa Z., Sheldon L.S. Assessing the quantitative relationships between Preschool Children's exposures to bisphenol A by route and urinary biomonitoring. Environ. Sci. Technol. 2011, 45:5309-5316.
58. Mortensen M.E., Calafat A.M., Ye X., Wong L.Y., Wright D.J., Pirkle J.L., Merrill L.S., Moye J. Urinary concentrations of environmental phenols in pregnant women in a pilot study of the National Children's Study. Environ. Res. 2014, 129:32-38.
59. Nahar M.S., Liao C., Kannan K., Harris C., Dolinoy D.C. In utero bisphenol A concentration, metabolism, and global DNA methylation across matched placenta, kidney, and liver in the human fetus. Chemosphere 2015, 124:54-60.
60. NAMPA NPD National Eating Trends 2013 Update 2014.
61. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., Tao L., Kannan K. Maternal bisphenol-A levels at delivery: a looming problem?. J. Perinatol. 2008, 28:258-263.
62. Patterson T.A., Twaddle N.C., Roegge C.S., Callicott R.J., Fisher J.W., Doerge D.R. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol. Appl. Pharmacol. 2013, 267:41-48.
63. Perera F., Vishnevetsky J., Herbstman J.B., Calafat A.M., Xiong W., Rauh V., Wang S. Prenatal bisphenol a exposure and child behavior in an inner-city cohort. Environ. Health Perspect. 2012, 120:1190-1194.
64. Philippat C., Mortamais M., Chevrier C., Petit C., Calafat A.M., Ye X., Silva M.J., Brambilla C., Pin I., Charles M.A., Cordier S., Slama R. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ. Health Perspect. 2012, 120:464-470.
65. Porras S.P., Heinala M., Santonen T. Bisphenol A exposure via thermal paper receipts. Toxicol. Lett. 2014, 230:413-420.
66. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 2000, 54:3-18.
67. Pritchett J.J., Kuester R.K., Sipes I.G. Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab. Dispos. 2002, 30:1180-1185.
68. Rezg R., El-Fazaa S., Gharbi N., Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ. Int. 2014, 64:83-90.
69. Ritchie M.R., Cummings J.H., Morton M.S., Michael Steel C., Bolton-Smith C., Riches A.C. A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intake. Br. J. Nutr. 2006, 95:204-213.
70. Robledo C., Peck J.D., Stoner J.A., Carabin H., Cowan L., Koch H.M., Goodman J.R. Is bisphenol-A exposure during pregnancy associated with blood glucose levels or diagnosis of gestational diabetes?. J. Toxicol. Environ. Health A 2013, 76:865-873.
71. Rochester J.R. Bisphenol A and human health: a review of the literature. Reprod. Toxicol. 2013, 42:132-155.
72. Romano M.E., Webster G.M., Vuong A.M., Thomas Zoeller R., Chen A., Hoofnagle A.N., Calafat A.M., Karagas M.R., Yolton K., Lanphear B.P., Braun J.M. Gestational urinary bisphenol A and maternal and newborn thyroid hormone concentrations: the HOME Study. Environ. Res. 2015, 138:453-460.
73. Rostami-Hodjegan A. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin. Pharmacol. Ther. 2012, 92:50-61.
74. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110:A703-707.
75. Shin B.S., Hwang S.W., Bulitta J.B., Lee J.B., Yang S.D., Park J.S., Kwon M.C., Kim do J., Yoon H.S., Yoo S.D. Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 2010, 73:1586-1598.
76. Shin B.S., Yoo S.D., Cho C.Y., Jung J.H., Lee B.M., Kim J.H., Lee K.C., Han S.Y., Kim H.S., Park K.L. Maternal-fetal disposition of bisphenol a in pregnant Sprague-Dawley rats. J. Toxicol. Environ. Health A 2002, 65:395-406.
77. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C., Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 2000, 168:225-234.
78. Takahashi O., Oishi S. Disposition of orally administered 2,2-Bis(4-hydroxyphenyl)propane (Bisphenol A) in pregnant rats and the placental transfer to fetuses. Environ. Health Perspect. 2000, 108:931-935.
79. Tan B.L., Ali Mohd M. Analysis of selected pesticides and alkylphenols in human cord blood by gas chromatograph-mass spectrometer. Talanta 2003, 61:385-391.
80. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., Toutain P.L., Laffont C.M., VandeVoort C.A. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. 2011, 119:422-430.
81. Teeguarden J., Hanson-Drury S., Fisher J.W., Doerge D.R. Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population?. Food Chem. Toxicol. 2013, 62:949-963.
82. Teeguarden J.G., Barton H.A. Computational modeling of serum-binding proteins and clearance in extrapolations across life stages and species for endocrine active compounds. Risk Anal. 2004, 24:751-770.
83. Teeguarden J.G., Calafat A.M., Ye X., Doerge D.R., Churchwell M.I., Gunawan R., Graham M.K. Twenty-four hour human urine and serum profiles of bisphenol A during high-dietary exposure. Toxicol. Sci. 2011, 123:48-57.
84. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95:300-312.
85. Teeguarden J.G., Mikheev V.B., Minard K.R., Forsythe W.C., Wang W., Sharma G., Karin N., Tilton S.C., Waters K.M., Asgharian B., Price O.R., Pounds J.G., Thrall B.D. Comparative iron oxide nanoparticle cellular dosimetry and response in mice by the inhalation and liquid cell culture exposure routes. Part Fibre Toxicol. 2014, 11:46.
86. Teeguarden J.G., Twaddle N., Churchwell M.I., Yang X., Fisher J.W., Seryak L.M., Doerge D.R. 24-hour human urine and serum profiles of bisphenol A: evidence against sublingual absorption following ingestion in soup. Toxicol. Appl. Pharmacol. 2015, 288:131-142.
87. Teeguarden J.G., Waechter J.M., Clewell H.J., Covington T.R., Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 2005, 85:823-838.
88. Thayer K.A., Doerge D., Hunt D., Schurman S.H., Twaddle N., Churchwell M., Grarantziotis S., Kissling G.E., Easterling M.R., Bucher J.R., Birnbaum L.S. Pharmacokineticis of bisphenol A in humans following dermal Administration. National Toxicology Program, RTP, NC 2015, J.G. Teeguarden (Ed.).
89. Thayer K.A., Doerge D.R., Hunt D., Schurman S.H., Twaddle N.C., Churchwell M.I., Garantziotis S., Kissling G.E., Easterling M.R., Bucher J.R., Birnbaum L.S. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ. Int. 2015, 83:107-115.
90. Thayer K.A., Taylor K.W., Garantziotis S., Schurman S., Kissling G.E., Hunt D., Herbert B., Church R., Jankowich R., Churchwell M.I., Scheri R.C., Birnbaum L.S., Bucher J.R. Bisphenol A, bisphenol S, and 4-Hydroxyphenyl 4-Isoprooxyphenylsulfone (BPSIP) in urine and blood of cashiers. Environ. Health Perspect. 2015, 124:437-444.
91. Trdan Lusin T., Roskar R., Mrhar A. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay. Toxicol. 2012, 292:33-41.
92. Twaddle N.C., Churchwell M.I., Vanlandingham M., Doerge D.R. Quantification of deuterated bisphenol A in serum, tissues, and excreta from adult Sprague-Dawley rats using liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24:3011-3020.
93. Unal E.R., Lynn T., Neidich J., Salazar D., Goetzl L., Baatz J.E., Hulsey T.C., Van Dolah R., Guillette L.J., Newman R. Racial disparity in maternal and fetal-cord bisphenol A concentrations. J. Perinatol. 2012, 32:844-850.
94. Valentin-Blasini L., Blount B.C., Caudill S.P., Needham L.L. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J. Expo. Anal. Environ. Epidemiol. 2003, 13:276-282.
95. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
96. Vandenberg L.N., Hunt P.A., Myers J.P., Frederick S.v.S. Human expsoures to bisphenol A: mismatches between data and assumptions. Rev. Environ. Health 2013, 28:37-58.
97. Vandentorren S., Zeman F., Morin L., Sarter H., Bidondo M.L., Oleko A., Leridon H. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ. Res. 2011, 111:761-764.
98. Veiga-Lopez A., Kannan K., Liao C., Ye W., Domino S.E., Padmanabhan V. Gender-specific effects on gestational length and birth weight by early pregnancy BPA exposure. J. Clin. Endocrinol. Metab. 2015, 100:E1394-E1403. jc20151724.
99. Veiga-Lopez A., Pennathur S., Kannan K., Patisaul H.B., Dolinoy D.C., Zeng L., Padmanabhan V. Impact of gestational bisphenol A on oxidative stress and free fatty acids: human association and interspecies animal testing studies. Endocrinol. 2015, 156:911-922.
100. Volberg V., Harley K., Calafat A.M., Dave V., McFadden J., Eskenazi B., Holland N. Maternal bisphenol a exposure during pregnancy and its association with adipokines in Mexican-American children. Environ. Mol. Mutagen 2013, 54:621-628.
101. Völkel W., Bittner N., Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 2005, 33:1748-1757.
102. Völkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.
103. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., Farabollini F., Guillette L.J., Hauser R., Heindel J.J., Ho S.M., Hunt P.A., Iguchi T., Jobling S., Kanno J., Keri R.A., Knudsen K.E., Laufer H., LeBlanc G.A., Marcus M., McLachlan J.A., Myers J.P., Nadal A., Newbold R.R., Olea N., Prins G.S., Richter C.A., Rubin B.S., Sonnenschein C., Soto A.M., Talsness C.E., Vandenbergh J.G., Vandenberg L.N., Walser-Kuntz D.R., Watson C.S., Welshons W.V., Wetherill Y., Zoeller R.T. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 2007, 24:131-138.
104. Vom Saal F.S., VandeVoort C.A., Taylor J.A., Welshons W.V., Toutain P.L., Hunt P.A. Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: relevance for human exposures. Reprod. Toxicol. 2014, 45:105-116.
105. Vom Saal F.S., Welshons W.V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell Endocrinol. 2014, 398:101-113.
106. Wambaugh J.F., Wang A., Dionisio K.L., Frame A., Egeghy P., Judson R., Setzer R.W. High throughput heuristics for prioritizing human exposure to environmental chemicals. Environ. Sci. Technol. 2014, 48:12760-12767.
107. Wambaugh J.F., Wetmore B.A., Pearce R., Strope C., Goldsmith R., Sluka J.P., Sedykh A., Tropsha A., Bosgra S., Shah I., Judson R., Thomas R.S., Woodrow Setzer R. Toxicokinetic triage for environmental chemicals. Toxicol. Sci. 2015, 147:55-67.
108. Wan Y., Choi K., Kim S., Ji K., Chang H., Wiseman S., Jones P.D., Khim J.S., Park S., Park J., Lam M.H., Giesy J.P. Hydroxylated polybrominated diphenyl ethers and bisphenol A in pregnant women and their matching fetuses: placental transfer and potential risks. Environ. Sci. Technol. 2010, 44:5233-5239.
109. Watkins D.J., Tellez-Rojo M.M., Ferguson K.K., Lee J.M., Solano-Gonzalez M., Blank-Goldenberg C., Peterson K.E., Meeker J.D. In utero and peripubertal exposure to phthalates and BPA in relation to female sexual maturation. Environ. Res. 2014, 134:233-241.
110. Wetmore B.A. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment. Toxicol. 2015, 332:94-101.
111. Wetmore B.A., Wambaugh J.F., Allen B., Ferguson S.S., Sochaski M.A., Setzer R.W., Houck K.A., Strope C.L., Cantwell K., Judson R.S., LeCluyse E., Clewell H.J., Thomas R.S., Andersen M.E. Incorporating high-throughput exposure predictions with dosimetry-adjusted in vitro bioactivity to inform chemical toxicity testing. Toxicol. Sci. 2015, 148:121-136.
112. Wetmore B.A., Wambaugh J.F., Ferguson S.S., Sochaski M.A., Rotroff D.M., Freeman K., Clewell H.J., Dix D.J., Andersen M.E., Houck K.A., Allen B., Judson R.S., Singh R., Kavlock R.J., Richard A.M., Thomas R.S. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol. Sci. 2012, 125:157-174.
113. Wolff M.S., Engel S.M., Berkowitz G.S., Ye X., Silva M.J., Zhu C., Wetmur J., Calafat A.M. Prenatal phenol and phthalate exposures and birth outcomes. Environ. Health Perspect. 2008, 116:1092-1097.
114. World Health Organization Toxicological and Health Aspects of Bisphenol A: Report of Joint FAO/WHO Expert Meeting 2-5 November 2010 and Report of Stakeholder Meeting on Bisphenol A 2011, 60. World Health Organization, Ottawa, CA.
115. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., Sata F., Kishi R., Fujimoto S. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 2002, 16:735-739.
116. Yang x. BPA PBPK Model II Placeholder 2015.
117. Yang X., Doerge D.R., Fisher J.W. Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model. Toxicol. Appl. Pharmacol. 2013, 270:45-59.
118. Yang X., Doerge D.R., Teeguarden J.G., Fisher J.W. Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A. Toxicol. Appl. Pharmacol. 2015, 289:442-456.
119. Ye X., Pierik F.H., Hauser R., Duty S., Angerer J., Park M.M., Burdorf A., Hofman A., Jaddoe V.W., Mackenbach J.P., Steegers E.A., Tiemeier H., Longnecker M.P. Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the generation R study. Environ. Res. 2008, 108:260-267.
120. Ye X., Wong L.Y., Bishop A.M., Calafat A.M. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ. Health Perspect. 2011, 119:983-988.
121. Ye X., Zhou X., Hennings R., Kramer J., Calafat A.M. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ. Health Perspect. 2013, 121:283-286.
122. Yoo S.D., Shin B.S., Kwack S.J., Lee B.M., Park K.L., Han S.Y., Kim H.S. Pharmacokinetic disposition and tissue distribution of bisphenol A in rats after intravenous administration. J. Toxicol. Environ. Health A 2000, 61:131-139.
123. Yoo S.D., Shin B.S., Lee B.M., Lee K.C., Han S.Y., Kim H.S., Kwack S.J., Park K.L. Bioavailability and mammary excretion of bisphenol a in Sprague-Dawley rats. J. Toxicol. Environ. Health A 2001, 64:417-426.
124. Zhang T., Sun H., Kannan K. Blood and urinary bisphenol A concentrations in children, adults, and pregnant women from china: partitioning between blood and urine and maternal and fetal cord blood. Environ. Sci. Technol. 2013, 47:4686-4694.